Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Clinical trial NCT06393452 · COMPLETED

Trial details

NCT number: NCT06393452
Sponsor: Pelage Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Androgenetic Alopecia

Start date: 2024-06-05
Primary completion: 2025-07-16
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.